Medicina, Dermatología y Toxicología
Departamento
Instituto de Investigaciones Biomédicas Alberto Sols
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigaciones Biomédicas Alberto Sols (9)
2024
-
Fibroblast growth factor 21 is a hepatokine involved in MASLD progression
United European Gastroenterology Journal, Vol. 12, Núm. 8, pp. 1056-1068
2023
-
Maresin 1 activates brown adipose tissue and promotes browning of white adipose tissue in mice
Molecular Metabolism, Vol. 74
2022
-
Pro-vegetarian food patterns and cardiometabolic risk in the PREDIMED-Plus study: a cross-sectional baseline analysis
European Journal of Nutrition, Vol. 61, Núm. 1, pp. 357-372
2021
-
Longitudinal changes in adherence to the portfolio and DASH dietary patterns and cardiometabolic risk factors in the PREDIMED-Plus study
Clinical Nutrition, Vol. 40, Núm. 5, pp. 2825-2836
-
Validity of the energy-restricted Mediterranean Diet Adherence Screener
Clinical Nutrition, Vol. 40, Núm. 8, pp. 4971-4979
2020
-
Dietary polyphenol intake is associated with HDL-cholesterol and a better profile of other components of the metabolic syndrome: A PREDIMED-plus sub-study
Nutrients, Vol. 12, Núm. 3
-
The effect of physical activity and high body mass index on health-related quality of life in individuals with metabolic syndrome
International Journal of Environmental Research and Public Health, Vol. 17, Núm. 10
2019
-
Impact of dietary lipoic acid supplementation on liver mitochondrial bioenergetics and oxidative status on normally fed Wistar rats
International Journal of Food Sciences and Nutrition, Vol. 70, Núm. 7, pp. 834-844
2015
-
Essential role of Nrf2 in the protective effect of lipoic acid against lipoapoptosis in hepatocytes
Free Radical Biology and Medicine, Vol. 84, pp. 263-278